Cantitate/Preț
Produs
Total produse
Vezi coșul
Biotargets of Cancer in Current Clinical Practice de Mauro Bologna

Biotargets of Cancer in Current Clinical Practice: Current Clinical Pathology

Editat de Mauro Bologna
en Limba Engleză Hardback – 5 apr 2012
Biotargets of Cancer in Current Clinical Practice presents an updated and reasoned review of the current status of knowledge concerning the major cancer types with a special focus on the current biomarkers, genes involved and the potential future targets of innovative therapies. The volume includes for each major cancer type, a comprehensive although concise discussion of epidemiology, affirmed and innovative biomarkers for diagnosis, and descriptions of the relevant genes for prognosis and (individualized) therapy through biotarget-specific new molecular treatments, with the latest information on the validation status of each novel biomarker. Individual chapters are dedicated to the major cancer types, plus a special chapter on metastasis. The present debate on patentability of genetic information applied to diagnostics and therapeutics of cancer is also discussed.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 177467 lei  6-8 săpt.
  Humana Press Inc. – 23 aug 2016 177467 lei  6-8 săpt.
Hardback (1) 141387 lei  6-8 săpt.
  Humana Press Inc. – 5 apr 2012 141387 lei  6-8 săpt.

Din seria Current Clinical Pathology

  • 5% Cardiovascular Complications in Cancer Therapy
    Preț: 71523 lei
  • 5% Practical Immunopathology of the Skin
    Preț: 107799 lei
  • 5% Handbook of Clinical Laboratory Testing During Pregnancy
    Preț: 141118 lei
  • 5% Breast Cancer and its Precursor Lesions: Making Sense and Making It Early
    Preț: 69770 lei
  • 5% Cutaneous Neural Neoplasms: A Practical Guide
    Preț: 107531 lei
  • 5% Surgical Pathology of Endocrine and Neuroendocrine Tumors
    Preț: 99285 lei
  • 5% Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma
    Preț: 139329 lei
  • 5% Gestational Trophoblastic Disease: Diagnostic and Molecular Genetic Pathology
    Preț: 107621 lei
  • 5% Cytology and Surgical Pathology of Gynecologic Neoplasms
    Preț: 108229 lei
  • 5% Pathology of Vascular Skin Lesions: Clinicopathologic Correlations
    Preț: 140347 lei
  • 5% Molecular Diagnostics in Dermatology and Dermatopathology
    Preț: 141209 lei
  • 5% Diagnostic, Prognostic and Therapeutic Value of Gene Signatures
    Preț: 107440 lei
  • 5% Cardiac Tumor Pathology
    Preț: 97113 lei
  • 5% Skin Cancer: A Practical Approach
    Preț: 111650 lei
  • 5% Kidney Development in Renal Pathology
    Preț: 36187 lei
  • 5% Well-Differentiated Malignancies: New Perspectives
    Preț: 66365 lei
  • 5% Targeted Therapies for Solid Tumors: A Handbook for Moving Toward New Frontiers in Cancer Treatment
    Preț: 71254 lei
  • 5% Amyloid and Related Disorders: Surgical Pathology and Clinical Correlations
    Preț: 110166 lei
  • 5% Advanced Imaging Techniques in Clinical Pathology
    Preț: 35682 lei
  • 5% Radiobiology of Glioblastoma: Recent Advances and Related Pathobiology
    Preț: 69311 lei
  • 5% Liquid Biopsy in Cancer Patients: The Hand Lens for Tumor Evolution
    Preț: 79137 lei
  • 5% Gastric Cancer In The Precision Medicine Era: Diagnosis and Therapy
    Preț: 80140 lei
  • 5% Adipocytic, Vascular and Skeletal Muscle Tumors: A Practical Diagnostic Approach
    Preț: 33142 lei
  • 5% Cardio-Oncology: Management of Toxicities in the Era of Immunotherapy
    Preț: 63222 lei
  • 5% Lung Pathology
    Preț: 210197 lei

Preț: 141387 lei

Preț vechi: 148828 lei
-5% Nou

Puncte Express: 2121
Preț estimativ în valută:
27067€ • 28176$ • 22283£

Carte tipărită la comandă

Livrare economică 31 ianuarie-14 februarie 25

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781617796142
ISBN-10: 161779614X
Pagini: 580
Ilustrații: XVI, 564 p.
Dimensiuni: 178 x 254 x 38 mm
Greutate: 1.25 kg
Ediția:2012
Editura: Humana Press Inc.
Colecția Humana
Seria Current Clinical Pathology

Locul publicării:Totowa, NJ, United States

Public țintă

Professional/practitioner

Cuprins

Central Nervous System Tumors.- Head and Neck Tumors.- Thyroid Cancer.- Targeted Therapies for Non-Small Cell Lung Cancer.- Non-Hodgkin Lymphomas.- Leukemias.- Breast Cancer.- Esophago-Gastric Cancer.- Colorectal Cancer.- Hepatocellular Carcinoma.- Biomarkers for Prognosis and Molecularly Targeted Therapy in Renal Cell Carcinoma.- Bladder Cancer.- Biomarkers in Prostate cancer.- Ovarian Cancer.- Uterine Cancer: The Influence of Genetics and Environment on Cell Cycling Pathways in Cancer.- Biotargets in Sarcomas: The Past, Present and a Look into the Future.- Melanoma and other skin cancers.- Molecular pathology of cancer metastasis: suggestions for future therapy.- Current and future developments in cancer therapy research: miRNAs as new promising targets or tools.

Recenzii

From the reviews:
“In this book on clinically significant biotargets in cancer research, every organ system is thoroughly represented with adequate overviews and precise details of the biotargets. … the book is intended specifically for clinicians in the field, including medical students, residents, pathologists, and oncologists. … This is a well-written book that attempts to provide a wide spectrum of current scientific information about the clinical management of oncologic patients based on molecular aspects. … this book achieves its objectives while remaining easy to read.” (Natalie Webster, Doody’s Review Service, October, 2012)

Notă biografică

Mauro Bologna, MD
University of L’Aquila, L’Aquila, Italy

Textul de pe ultima copertă

Biotargets of Cancer in Current Clinical Practice presents an updated and reasoned review of the current status of knowledge concerning the major cancer types with a special focus on the current biomarkers, genes involved and the potential future targets of innovative therapies. The volume includes for each major cancer type, a comprehensive although concise discussion of epidemiology, affirmed and innovative biomarkers for diagnosis, and descriptions of the relevant genes for prognosis and (individualized) therapy through biotarget-specific new molecular treatments, with the latest information on the validation status of each novel biomarker. Individual chapters are dedicated to the major cancer types, plus a special chapter on metastasis. The present debate on patentability of genetic information applied to diagnostics and therapeutics of cancer is also discussed.

Caracteristici

Provides the latest information on the validation status of each novel biomarker Covers the present debate on potential clinical use of newly discovered biochemical markers and on patentability of genetic information Chapter authors are experts on the particular cancer type